Follistatins in glucose regulation of healthy and obese subjects

AIMS: It has been recently suggested that follistatin (FST) and its homologous protein, follistatin-like 3 (FSTL3) may be a therapeutic target against type 2 diabetes due to their glucose-regulatory effects in rodents. MATERIALS AND METHODS: We investigated this hypothesis in humans by studying i) t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diabetes Obes Metab
Egile Nagusiak: Perakakis, Nikolaos, Kokkinos, Alexander, Peradze, Natia, Tentolouris, Nicholas, Ghaly, Wael, Tsilingiris, Dimitrios, Alexandrou, Andreas, Mantzoros, Christos S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6368471/
https://ncbi.nlm.nih.gov/pubmed/30393997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13572
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak